Prescient Therapeutics
Follow
Follow Organisations, People and Lists
Stay on top of the latest updates for your desired data.
Prescient Therapeutics, formerly known as Virax Holdings, is a clinical stage oncology company developing novel compounds that show great promise as potential new therapies to treat a range of cancers that have become resistant to front line chemotherapy.
Contact Details
Level 4, 100 Albert Road, SOUTH MELBOURNE VIC 3205
03 9692 7222
Lists and Charts
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Collapse All Lists and Charts
Article Timeline
Related Information
Notable People
| Name | Position | Year Started |
|---|---|---|
| Non-Executive Director | 2014 |
| Non-Executive Chairman | 2014 |
| Non-Executive Director Executive Director (2014 to 2017) | 2017 |
| Vice President, Business Development | 2018 |
| Chief Executive Officer, Managing Director | 2014 |
Past People
| Name | Position | Year Started | Year Ended |
|---|---|---|---|
| Paul Hopper | Executive Director | 2014 | 2017 |
| Sean Henbury | Company Secretary | 2013 | 2015 |
| Rob Crombie | Managing Director | 2014 | 2015 |
| Wayne Millen | Non-Executive Chairman | 2013 | 2014 |
| Brendan de Kauwe | Non-Executive Director | 2013 | 2014 |
| Roland Toder | Non-Executive Director | 2013 | 2014 |
ECM Deals
| Date | Company | Transaction Type | Total Value | |
|---|---|---|---|---|
| 30/06/16 | Prescient Therapeutics | Entitlement offer | $3.4m | >> |
| 18/05/16 | Prescient Therapeutics | Placement | $7.0m | >> |
| 23/11/15 | Prescient Therapeutics | Entitlement offer | $1.0m | >> |
| 28/03/14 | Prescient Therapeutics | Placement | $3.0m | >> |
M&A Deals
| Announced | Bidder | Target | Transaction Type | Total Value | |
|---|---|---|---|---|---|
| 17/03/14 | Prescient Therapeutics | Pathway Oncology | Reverse takeover | $3.6m | >> |
